The content of this website is intended for healthcare professionals only

Testosterone for menopausal women

Portfolio politics

Louise Newson

Tuesday, 11 October 2016

Add to PDP Tracker

testosterone_shutterstock_399632482.jpgLast weekend, various newspapers reported on a presentation that Nick Panay, a gynaecologist and menopause expert, gave at the RCGP’s annual conference. In this presentation, he stated that women suffering from a loss of sexual desire should be offered testosterone on the NHS.

Reduced or lack of libido is very common in menopausal women and the NICE guidance on the management of the menopause clearly states that women with low libido should be considered for testosterone.

Testosterone can also improve women's energy, mood and concentration. However, in the UK, testosterone is not licenced for women, unlike in other countries (including Australia).

Interestingly, women produce three times more testosterone than oestrogen before their menopause. It is an important hormone which is often overlooked. Adequate levels of testosterone are important for the maintenance of musculoskeletal health and also possibly vascular and brain function. Observational studies indicate that testosterone has favourable cardiovascular effects measured by surrogate outcomes; however, associations between endogenous testosterone and the risk of cardiovascular disease and total mortality, particularly in older women, are yet to be established. Reassuringly, adverse cardiovascular effects have not been seen in studies of transdermal testosterone therapy in women.

Numerous studies have shown that adding testosterone to hormonal therapy can improve sexual function and general wellbeing among women during their menopause. In addition, using transdermal testosterone can improve cognition and also improve verbal learning and memory.

Testosterone appears to be safe when used transdermally and in low doses. Its use is not associated with breast or endometrial cancer. It appears to offer some bone protection and also reduces the incidence of sacropenia.

Testosterone levels do not actually correlate well with female sexual function or overall wellbeing as it is difficult to accurately measure the free and total testosterone levels at the lower end of the female range.

It can sometime take several weeks, even months for a woman to notice the beneficial effects of testosterone. If they have not noticed an improvement after six months, then it is unlikely to be beneficial. However, for most women taking testosterone can really make a huge difference to the quality of their lives.

We should have a lower threshold for talking to women about their sex drives and then for considering giving testosterone for those women with low libido.

Author's Image

Louise Newson

Louise is a part-time GP in Solihull, as well as a writer for numerous medical publications, including She is an Editor and Reviewer for e-learning courses for the RCGP. She is an Editor for Geriatric Medicine journal and the British Journal of Family Medicine. Louise has contributed to various healthcare articles in many different newspapers and magazines and is the spokesperson for The Information Standard. She has also done television and radio work. Louise is a medical consultant for Maverick TV and has participated regularly in ‘Embarrassing Bodies Live from the Clinic’. Louise has three young children and is married to a consultant urological surgeon. Although her spare time is limited she enjoys practising ashtanga yoga regularly and loves road cycling – she has raised over £2K for a local charity, Molly Olly Wishes by competing in a 120km cycle ride!

Do you think vulnerable GP practices receive adequate support? (See OnMedica News 13/10)

Banner for OnMedica News
FAD Banner
Wilmington Healthcare Limited, 6-14 Underwood Street, London, England, N1 7JQ
Registered in England and Wales, Reg No. 2530185